InfoMedSearch Newsletters
Lung Cancer

:: Jun-Jul 2008


Welcome to our Monthly Online Newsletter!


View all Treatment articles in our Treatment Report . The most recent articles are listed on top (not in alphabetical order). Click on the Topic on our home page and then the subtopic - Treatment Report. Stay updated on drugs and their side effects, and various other treatments, including exercise, nutrition, and supplements.

Highlighted Article

Repeated Past Article:

Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. (Mayo Clin Proc. 2008) “Non-small cell lung cancer accounts for 85% of all lung cancer cases in the United States. After the initial diagnosis, accurate staging of non-small cell lung cancer using computed tomography or positron emission tomography is crucial for determining appropriate therapy. When feasible, surgical resection remains the single most consistent and successful option for cure. However, close to 70% of patients with lung cancer present with locally advanced or metastatic disease at the time of diagnosis. Chemotherapy is beneficial for patients with metastatic disease, and the administration of concurrent chemotherapy and radiation is indicated for stage III lung cancer.”

Clinical Guidelines

ACCP Revises Guideline on the Diagnosis of Lung Cancer (2nd Edition)

DIAGNOSIS AND MANAGEMENT OF LUNG CANCER: ACCP GUIDELINES (2ND EDITION) – LISTED GUIDELINES (Chest. 2007)

Diagnostic surgical pathology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). (Chest. 2007)

Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). (Chest. 2007)

Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). (Chest. 2007)

Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). (Chest. 2007)

Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines (2nd edition). (Chest. 2007)

Lung cancer chemoprevention: ACCP evidence-based clinical practice guidelines (2nd Edition). (Chest. 2007)

National Comprehensive Cancer Network (NCCN) Non-Small Cell Lung Cancer Guideline, Version 1.2007 (2007)

New Guidelines Issued on Lung Cancer Diagnosis and Management (2007)

NGC - Cross-sectional diagnostic imaging in lung cancer. (2006)

NGC - Diagnostic surgical pathology in lung cancer: ACCP evidence-based clinical practice guidelines. (2nd Edition) (2007)

NGC - Evaluation of patients with pulmonary nodules: when is it lung cancer? ACCP evidence-based clinical practice guidelines. (2nd Edition) (2007)

NGC – Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines. (2nd Edition) (2007)

Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). (Chest. 2007)

Internet Sites

Related InfoMedSearch Topics

Related Topics - Highlighted Articles

 

Diagnosis, Imaging, and Screening

Can FDG-PET be used to predict growth of stage I lung cancer? (Clin Radiol. 2008) “CONCLUSIONS: For stage I lung tumours, there is a significant relationship between growth rates, as measured by serial CT examinations, and the initial pre-treatment metabolic activities, as measured by FDG uptake. This suggests that in patients in whom it is difficult to decide on the aggressiveness on treatment, FDG-PET may be used as additional prognostic tool for determining management.”

 

General Information

 

Risk Factors

 

Risk Reduction
© 2004-2008 InfoMedSearch, LLC. All Rights Reserved. | Design: mqstudio | Disclaimer